CareDx Collaborates with Weill Cornell Medicine to Lead the Development and Commercialization of UroMap
Adding UroMap to CareDx’s suite of kidney transplant solutions, which includes AlloSure® and KidneyCare™, may potentially provide healthcare professionals a comprehensive view of immune and injury status of the transplanted kidney. CareDx’s solutions enable cutting-edge patient management and support optimizing immunosuppression.
“UroMap provides early detection and quantification of clinically relevant cellular rejection,” said
“We are delighted to announce this collaboration with Weill Cornell Medicine to help bring UroMap’s rapid allograft rejection detection capabilities to our industry-leading suite of transplant care solutions,” said
Chief Marketing Officer
Source: CareDx, Inc.